FLT3 and acute myeloid leukemia: Significance were still observed after including two additional normal karyotype AML patient samples with FLT3–ITD and NPM1wt and cells with FLT3–ITD mutations showed a distinct trend toward significance (Figures 2g; P=0.073) suggesting an AVA-sensitizing role for FLT3–ITD mutations.